Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase
- PMID: 697902
- DOI: 10.1016/0006-2952(78)90493-8
Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase
Similar articles
-
Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.Biochem Pharmacol. 1977 Jun 1;26(11):1059-63. doi: 10.1016/0006-2952(77)90244-1. Biochem Pharmacol. 1977. PMID: 18152 No abstract available.
-
The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.J Pharmacol Exp Ther. 1974 Jun;189(3):733-40. J Pharmacol Exp Ther. 1974. PMID: 4843170 No abstract available.
-
[Brain monoamine oxidase in craniocerebral trauma].Vopr Med Khim. 1984 Jan-Feb;30(1):75-7. Vopr Med Khim. 1984. PMID: 6710942 Russian.
-
Monoamine oxidase: examination of multiple forms.Life Sci. 1977 Jun 15;20(12):1925-33. doi: 10.1016/0024-3205(77)90170-9. Life Sci. 1977. PMID: 329033 Review. No abstract available.
-
[Mechanism of the pharmacological effect of monoamine oxidase inhibitors].Vestn Akad Med Nauk SSSR. 1984;(11):72-5. Vestn Akad Med Nauk SSSR. 1984. PMID: 6396999 Review. Russian. No abstract available.
Cited by
-
Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.J Neural Transm (Vienna). 1997;104(6-7):593-603. doi: 10.1007/BF01291878. J Neural Transm (Vienna). 1997. PMID: 9444560
-
The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions.Naunyn Schmiedebergs Arch Pharmacol. 1983 Apr;322(3):198-202. doi: 10.1007/BF00500765. Naunyn Schmiedebergs Arch Pharmacol. 1983. PMID: 6408492
-
3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.Naunyn Schmiedebergs Arch Pharmacol. 1981 Jan;315(3):219-25. doi: 10.1007/BF00499838. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6261159 No abstract available.
-
Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis.Exp Mol Med. 2021 Jul;53(7):1148-1158. doi: 10.1038/s12276-021-00646-3. Epub 2021 Jul 9. Exp Mol Med. 2021. PMID: 34244591 Free PMC article.
-
Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.Psychopharmacology (Berl). 1980;72(1):27-33. doi: 10.1007/BF00433804. Psychopharmacology (Berl). 1980. PMID: 6781004 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources